Pfizer’s Exubera Flop
Needle-free insulin was supposed to be the next big thing in drugs. Turns out patients aren’t interested—it’ll cost Pfizer $2.8 billion
Original post by AnthonyK
Leave a Reply
You must be logged in to post a comment.
Needle-free insulin was supposed to be the next big thing in drugs. Turns out patients aren’t interested—it’ll cost Pfizer $2.8 billion
Original post by AnthonyK
You must be logged in to post a comment.